Table 3. Framingham Risk Score (FRS) According to Milk Consumption by Age.
Variables | FRS, mean (SE)/n (%) | ||
---|---|---|---|
20-39 yrs | 40-59 yrs | ≥60 yrs | |
Men (n) | 1740 | 2182 | 1796 |
Rarely | 1.41 (0.39)/255 (14.7) | 9.63 (0.12)/699 (32.0) | 13.56 (0.06)/852 (47.4) |
Monthly | 1.53 (0.34)/261 (15.0) | 9.83 (0.16)/417 (19.1) | 13.36 (0.11)/317 (17.7) |
Weekly | 1.06 (0.18)/812 (46.7) | 9.71 (0.12)/770 (35.3) | 13.32 (0.08)§/428 (23.8) |
Daily | 0.92 (0.23)/412 (23.7) | 9.45 (0.20)/296 (13.6) | 12.96 (0.12)*†‡/199 (11.1) |
P for trend | 0.383 | 0.512 | <0.001 |
Women (n) | 2685 | 3064 | 2269 |
Rarely | -1.61 (0.20)/405 (15.1) | 8.40 (0.12)/831 (27.1) | 16.69 (0.09)/1153 (50.8) |
Monthly | -1.20 (0.29)/336 (12.5) | 8.21 (0.14)/468 (15.3) | 16.50 (0.14)/302 (13.3) |
Weekly | -1.77 (0.14)/1102 (41.0) | 8.11 (0.11)/1116 (36.4) | 16.56 (0.14)/509 (22.4) |
Daily | -2.10 (0.15)/842 (31.4) | 8.19 (0.13)/649 (21.2) | 16.35 (0.15)/305 (13.4) |
P for trend | 0.018 | 0.332 | 0.222 |
FRS are expressed as mean (standard error). p values represent p for trends found via ANCOVA after adjusting for age, body mass index, job, alcohol intake, moderate physical activity, and serum 25-hydroxyvitamin D. Further adjustments were made for menopause, oral contraceptive use, and hormone replacement therapy in cases of women.
*p<0.05 in the comparison between rarely vs. daily, †p<0.05 in the comparison between monthly vs. daily, ‡p<0.05 in the comparison between weekly vs. daily, §p<0.05 in the comparison between monthly vs. weekly.